or Try an Advanced Search...

    Technical Analysis for CMMB - ChemomAb Therapeutics Ltd.

    Grade Last Price % Change Price Change
    F 0.73 -18.42% -0.16
    CMMB closed down 18.42 percent on Wednesday, May 8, 2024, on 4.22 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CMMB trend table...
    Date Alert Name Type % Chg
    Bearish Engulfing Bearish 0.00%
    Fell Below 200 DMA Bearish 0.00%
    Fell Below 50 DMA Bearish 0.00%
    Stochastic Sell Signal Bearish 0.00%
    Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
    20 DMA Support Bullish 0.00%
    Slingshot Bullish Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Older End-of-Day Signals for CMMB ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support about 12 hours ago
    20 DMA Support about 13 hours ago
    10 DMA Support about 13 hours ago
    50 DMA Support about 13 hours ago
    60 Minute Opening Range Breakdown about 13 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    CMMB Chart by TradingView
    Basic chart:

    Profile

    ChemomAb Ltd. develops therapeutic antibodies for the treatment of autoimmune and inflammatory diseases. The company is based in Tel Aviv, Israel.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Immunology Antibodies Monoclonal Antibody Autoimmunity Autoimmune And Inflammatory Disease

    Is CMMB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
    May 2 Chemomab Therapeutics to Present at 2024 Aegis Virtual Conference
    Apr 24 Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
    Apr 18 Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis
    Apr 2 Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
    Mar 25 Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis
    Mar 7 Chemomab Therapeutics GAAP EPS of -$0.01 beats by $0.01
    Mar 7 Chemomab Therapeutics Announces Year End and Fourth Quarter 2023 Financial Results and Provides a Corporate Update
    Mar 7 Earnings Scheduled For March 7, 2024
    Mar 5 Chemomab Therapeutics to Participate in Leerink Global BioPharma Conference
    See more CMMB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.89
    52 Week Low 0.42
    Average Volume 100,984
    200-Day Moving Average 0.77
    50-Day Moving Average 0.74
    20-Day Moving Average 0.71
    10-Day Moving Average 0.73
    Average True Range 0.09
    RSI (14) 48.98
    ADX 23.85
    +DI 24.68
    -DI 21.93
    Chandelier Exit (Long, 3 ATRs) 0.70
    Chandelier Exit (Short, 3 ATRs) 0.85
    Upper Bollinger Bands 0.85
    Lower Bollinger Band 0.58
    Percent B (%b) 0.55
    BandWidth 38.27
    MACD Line 0.01
    MACD Signal Line 0.00
    MACD Histogram 0.0151
    Fundamentals Value
    Market Cap 8.16 Million
    Num Shares 11.3 Million
    EPS -2.94
    Price-to-Earnings (P/E) Ratio -0.25
    Price-to-Sales 0.00
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.17
    Resistance 3 (R3) 1.18 1.04 1.10
    Resistance 2 (R2) 1.04 0.93 1.04 1.07
    Resistance 1 (R1) 0.88 0.86 0.81 0.87 1.05
    Pivot Point 0.74 0.74 0.71 0.74 0.74
    Support 1 (S1) 0.59 0.63 0.52 0.58 0.40
    Support 2 (S2) 0.45 0.56 0.44 0.38
    Support 3 (S3) 0.29 0.45 0.35
    Support 4 (S4) 0.28